Chapter 2 Class Antihypertensive Therapies Notes
Blood Pressure
Blood pressure (BP) is the force of blood on the arteries.
It is the product of Cardiac Output (CO) and Peripheral Vascular Resistance (PVR): BP = CO
eq PVRCardiac Output (CO) is the product of Stroke Volume and Heart Rate (HR): CO = Stroke Volume
eq HR
Blood Pressure Ranges
Normal: Systolic < 120 and Diastolic < 80
Elevated: Systolic 120-129 and Diastolic < 80
High BP Stage 1: Systolic 130-139 or Diastolic 80-89
High BP Stage 2: Systolic >= 140 or Diastolic >= 90
Hypertensive Crisis: Systolic > 180 and/or Diastolic > 120
Factors Contributing to Blood Pressure
Heart
Arteries
Kidneys
Risks
Causes of High Blood Pressure
Idiopathic/Genetic factors
Nervous System
Renin-Angiotensin System
Treatment Strategies
Lifestyle changes
Pharmacological therapies
Lifestyle Modifications
Lowering sodium intake
Weight loss/control
Aerobic/cardio exercise
Smoking cessation
Medication Classes for Hypertension
Diuretics
ACE Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Renin Inhibitors
Calcium Channel Blockers (CCBs)
Adrenergic Blockers
Vasodilators
Diuretics
Mechanism: Increase urine output, reducing blood volume.
Effect: Reduces Cardiac Output, leading to reduced blood pressure.
Loop Diuretics
Maximum effect diuretics.
Act on the Loop of Henle.
Inhibit co-transport of sodium, potassium, and chloride.
Examples: Lasix (furosemide) and Bumex (bumetanide).
Indications:
Edema due to renal, hepatic, or cardiac failure.
Heart failure management.
Acute Pulmonary Edema.
Hypercalcemia and hyperkalemia. (Note: This is likely a typo in the original transcript and should read "treatment of hypercalcemia")
Thiazide and Thiazide-like Diuretics
Examples: Chlorothiazide and Hydrochlorothiazide.
Act on the Loop of Henle and Distal Convoluted Tubule.
Inhibit sodium and chloride co-transporter.
Inhibit sodium reabsorption.
Increase sodium and chloride excretion.
Allow calcium reabsorption.
Prolonged use may result in an exchange of potassium ions for sodium, leading to potassium loss.
Medium efficacy.
Increased urine output lowers blood volume; volume will recover over time.
Arteriolar smooth muscle relaxation will lower vascular resistance.
Indications:
Mild to moderate hypertension.
Combined therapy with loop diuretics for heart failure.
Prevent excess calcium secretion in urine.
Adverse Effects:
Potassium depletion.
Hyponatremia.
Volume depletion.
Hyperuricemia.
Hypercalcemia.
Hyperglycemia.
Weaker Diuretics: Potassium Sparing
Act at the site of collecting ducts.
Inhibit sodium reabsorption.
Inhibit potassium excretion.
Can cause hyperkalemia.
Aldosterone Antagonists
Antagonist action to aldosterone receptors.
Prevents binding of aldosterone to receptors.
Indications:
Combined therapy with thiazide and/or loop diuretics.
Secondary hyperaldosteronism (spironolactone).
Resistant hypertension.
Heart failure (prevents remodeling of the heart).
Adverse Effects:
Spironolactone – gynecomastia, menstrual irregularities.
Hyperkalemia.
ACE Inhibitors (Angiotensin Converting Enzyme Inhibitors)
Kidneys release renin due to lowered blood pressure.
Renin converts angiotensinogen (from the liver) to Angiotensin I.
Angiotensin I is converted to Angiotensin II in the presence of ACE (in the lungs).
Angiotensin II is a potent vasoconstrictor.
ACE Inhibitors prevent the conversion of angiotensin I to angiotensin II.
Effects of ACE Inhibition:
Reduced vascular resistance.
Reduced sodium and water retention.
Decreased preload and afterload on the heart.
Indications:
Hypertension.
Congestive Heart Failure.
Myocardial Infarction.
Diabetic Nephropathy.
Adverse Effects:
Dry cough, fever, altered taste.
Headache, nausea.
Rash, urticaria, angioedema.
Hyperkalemia (do not combine with potassium-sparing diuretics).
Angiotensin II Receptor Blockers (ARBs)
Block Angiotensin II from binding to its receptors.
Results:
Reduction in blood volume.
Prevention of sodium and water reabsorption.
Lowered peripheral vascular resistance.
Renin Inhibitors
Aliskiren inhibits renin.
Should not be combined with ACE Inhibitors.
Calcium Channel Blockers (CCBs)
Prevents intracellular influx of calcium.
Calcium mediates cation potential and muscle contraction in smooth and cardiac muscle.
Decreases intracellular calcium and prevents action potential.
Actions:
Smooth Muscle relaxation
Negative inotrope (lowers contractility)
Negative chronotrope (lowers rate)
Negative dromotrope (lowers conduction)
Categories:
Diphenylalkylamines: Verapamil
Benzothiazepines: Diltiazem
Dihydropyridines: amlodipine, nifedipine
Indications:
Hypertension
Angina
Adverse Effects:
Constipation
Aggravate 1st Degree heart block
Headache
Fatigue
Peripheral Edema
Beta Adrenergic Blockers
Act on beta receptors in the heart to reduce cardiac output.
Reduce sympathetic stimulation of kidneys (inhibits renin).
Selective beta blockers work on the heart only.
Non-selective beta blockers can affect bronchials.
Alpha Adrenergic Blockers
Reduce blood pressure by relaxing vascular smooth muscle.
Examples: Prazosin, terazosin, doxazosin.
Combined Alpha/Beta Blockers
Example: Carvedilol
Drastic effects on blood pressure.
Centrally Acting A2 Antagonists
Decrease sympathetic Outflow
Relaxes blood vessels.
Vasodilators
Relaxes smooth muscle in arteries and arterioles.
Can lead to tachycardia.
Can lead to reflex stimulation of the heart.
Hypertensive Emergencies
Defined as a blood pressure of > 180/120 mmHg.
Causes include:
Sudden medication changes (e.g., abrupt cessation of beta blockers).
Medication interactions.
Adrenal gland tumors.
Symptoms:
Anxiety
Blurred vision
Chest pain
Severe headache
Seizures